IRCT20170513033941N23
Completed
Phase 3
Clinical trial of the effect of selenium supplementation compared with the placebo on gene expression related to inflammation in women with polycystic ovary syndrome candidate for IVF.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Polycystic ovarian syndrome.
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with polycystic ovary syndrome.
- •Individuals aged 18 to 40 years.
Exclusion Criteria
- •Metabolic abnormalities such as diabetes, impaired glucose tolerance and thyroid dysfunction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of supplementation in treatment of patients with gestational diabetesGestational diabetes.Diabetes mellitus in pregnancy, unspecifiedE28.2IRCT201612045623N95Vice chancellor for research, Arak University of Medical Sciences40
Completed
Phase 3
Effect of supplementation in treatment of women with polycystic ovary syndrome of IVF candidatePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT201704245623N113Vice chancellor for research, Shahid Beheshti University of Medical Sciences40
Completed
Phase 3
Effect of selenium supplementation in treatment of gestational diabetes mellitusIRCT20170513033941N35Iran University of Medical Sciences40
Completed
Phase 3
Effect of supplementation in treatment of pregnant women at risk for intrauterine growth restrictioPregnancy.Sequelae of complication of pregnancy, childbirth and the puerperiumIRCT201601045623N64Vice chancellor for research, Kashan University of Medical Sciences60
Completed
Phase 3
Effect of supplementation in treatment of Congestive Heart FailureIRCT2017053033941N2Vice chancellor for research, Kashan University of Medical Sciences60